Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy
- PMID: 35587623
- PMCID: PMC9321723
- DOI: 10.1002/mds.29011
Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy
Figures
= affected female,
= unaffected female,
= affected male,
= unaffected male, / = deceased individual, wt/wt = homozygous for wild‐type (normal) CSF1R allele, wt/mut = heterozygous for pathogenic CSF1R variant. Arrow points to individual III:2, recipient of prophylactic HSCT. Monozygotic twins II:5 and II:6 are NO‐2 and NO‐1, respectively, in Rademakers et al.2 Cause of death in all affected individuals was CSF1R‐related leukoencephalopathy: II:5 died at age 40 years, II:6 at age 41 years, III:4 at age 36 years, and III:5 at age 31 years.Comment in
-
Reply to "Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy".Mov Disord. 2022 May;37(5):1109-1110. doi: 10.1002/mds.29018. Mov Disord. 2022. PMID: 35587622 No abstract available.
Comment on
-
Treatment of CSF1R-Related Leukoencephalopathy: Breaking New Ground.Mov Disord. 2021 Dec;36(12):2901-2909. doi: 10.1002/mds.28734. Epub 2021 Jul 30. Mov Disord. 2021. PMID: 34329526
References
-
- Tipton PW, Kenney‐Jung D, Rush BK, et al. Treatment of CSF1R‐related leukoencephalopathy: breaking new ground. Mov Disord 2021;36:2901–2909. - PubMed
-
- Mochel F, Delorme C, Czernecki V, et al. Haematopoietic stem cell transplantation in CSF1R‐related adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia. J Neurol Neurosurg Psychiatry 2019;90:1375–1376. - PubMed
-
- Gelfand JM, Greenfield AL, Barkovich M, et al. Allogeneic HSCT for adult‐onset leukoencephalopathy with spheroids and pigmented glia. Brain 2020;143:503–511. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
